Development of a novel enzymatic cycling assay for total homocysteine

Clinical Chemistry

Volumn 51, Issue 10, 2005, Pages 1987-1989

  Dou, Chao ^a   Xia, Dongyuan ^a   Zhang, Liqing ^a   Chen, Xiaoru ^a   Flores, Patrick ^a   Datta, Abhijit ^a   Yuan, Chong ^a  

^a Diazyme Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENOSINE; ADENOSYLHOMOCYSTEINASE; AMINO ACID; AMMONIA; CYSTATHIONINE BETA LYASE; CYSTEINE; GLUTAMATE DEHYDROGENASE; HOMOCYSTEINE; HOMOCYSTEINE METHYLTRANSFERASE; INOSINE; METHIONINE; METHIONINE SYNTHASE; METHYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REAGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ACCURACY; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTERIOSCLEROSIS; BIOACCUMULATION; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHEMICAL REACTION; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DNA POLYMORPHISM; ENZYMATIC ASSAY; ENZYMATIC CYCLING ASSAY; HOMOCYSTINURIA; HUMAN; IMMUNOASSAY; IN VITRO STUDY; INTERNALIZATION; LABORATORY AUTOMATION; LABORATORY TEST; OXIDATION; QUANTITATIVE ANALYSIS; REFERENCE VALUE; TECHNIQUE;

BLOOD CHEMICAL ANALYSIS; ENZYMES; HOMOCYSTEINE; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 25444433564     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.053421     Document Type: Conference Paper

References (9)

1. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-75.
2. Scott J, Weir D. Homocysteine and cardiovascular disease. QJM 1996;89: 561-3.
3. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.
4. Seshadri S, Beiser A, Selhub S, Jacques PF, Rosenberg IH. D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:477-83.
5. McLean R, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004;350:2042-9.
6. Refsum H. Total homocysteine guidelines for determination in the clinical laboratory. Clin Lab News 2002;5:12-4.
7. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM. Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr 1994;124:1934-41.
8. Vilaseca MA, Moyano D, Ferrer I, Artuch R. Total homocysteine in pediatric patients. Clin Chem 1997;43:690-2.
9. Faure-Delanef L, Quere I, Chasse JF, Guerassimenko O, Lesaulnier M, Bellet H, et al. Methylenetetrariydrofolate reductase thermolabile variant and human longevity. Am J Hum Genet 1997;60:999-1001.